415 related articles for article (PubMed ID: 36077418)
1. Protective Effects of Flavonoids against Alzheimer's Disease: Pathological Hypothesis, Potential Targets, and Structure-Activity Relationship.
Li J; Sun M; Cui X; Li C
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077418
[TBL] [Abstract][Full Text] [Related]
2. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer's Disease.
Wang Q; Dong X; Zhang R; Zhao C
J Alzheimers Dis; 2021; 84(2):505-533. PubMed ID: 34569961
[TBL] [Abstract][Full Text] [Related]
4. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
5. Role of Flavonoids in Management of Various Biological Targets in Alzheimer's Disease: Evidence from Preclinical to Clinical Studies.
Alharbi KS; Javed Shaikh MA; Imam SS; Alshehri S; Ghoneim MM; Almalki WH; Singh SK; Kumar D; Kumar AP; Dua K; Chellappan DK; Paudel KR; Gupta G
Curr Med Chem; 2023; 30(18):2061-2074. PubMed ID: 36415096
[TBL] [Abstract][Full Text] [Related]
6. Magnetic chrysin silica nanomaterials behavior in an amyloidogenic environment.
Nday CM; Eleftheriadou D; Jackson G
Hell J Nucl Med; 2019; 22 Suppl():42-50. PubMed ID: 30877722
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of flavonoids in the management of obesity-induced Alzheimer's disease: an overview of preclinical and clinical studies.
Kothawade SM; Buttar HS; Tuli HS; Kaur G
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2813-2830. PubMed ID: 37231172
[TBL] [Abstract][Full Text] [Related]
8. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease.
Bastianetto S; Krantic S; Quirion R
Mini Rev Med Chem; 2008 May; 8(5):429-35. PubMed ID: 18473932
[TBL] [Abstract][Full Text] [Related]
9. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.
Baptista FI; Henriques AG; Silva AM; Wiltfang J; da Cruz e Silva OA
ACS Chem Neurosci; 2014 Feb; 5(2):83-92. PubMed ID: 24328060
[TBL] [Abstract][Full Text] [Related]
11. An insight into the neuroprotective effects and molecular targets of pomegranate (
George N; AbuKhader M; Al Balushi K; Al Sabahi B; Khan SA
Nutr Neurosci; 2023 Oct; 26(10):975-996. PubMed ID: 36125072
[TBL] [Abstract][Full Text] [Related]
12. Icariin ameliorate Alzheimer's disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis.
Chuang Y; Van I; Zhao Y; Xu Y
J Chem Neuroanat; 2021 Nov; 117():102014. PubMed ID: 34407393
[TBL] [Abstract][Full Text] [Related]
13. Scope of β-Secretase (BACE1)-Targeted Therapy in Alzheimer's Disease: Emphasizing the Flavonoid Based Natural Scaffold for BACE1 Inhibition.
Das S; Sengupta S; Chakraborty S
ACS Chem Neurosci; 2020 Nov; 11(21):3510-3522. PubMed ID: 33073981
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of flavonoids against Alzheimer's disease-related neural dysfunctions.
Bakhtiari M; Panahi Y; Ameli J; Darvishi B
Biomed Pharmacother; 2017 Sep; 93():218-229. PubMed ID: 28641164
[TBL] [Abstract][Full Text] [Related]
15. The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease.
Iqbal UH; Zeng E; Pasinetti GM
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664669
[TBL] [Abstract][Full Text] [Related]
16. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
Nakajima A; Ohizumi Y
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
[TBL] [Abstract][Full Text] [Related]
17. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
Maher P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
[TBL] [Abstract][Full Text] [Related]
18. Total flavonoid extract from Dracoephalum moldavica L. attenuates β-amyloid-induced toxicity through anti-amyloidogenesic and neurotrophic pathways.
Liu QS; Jiang HL; Wang Y; Wang LL; Zhang JX; He CH; Shao S; Zhang TT; Xing JG; Liu R
Life Sci; 2018 Jan; 193():214-225. PubMed ID: 29100755
[TBL] [Abstract][Full Text] [Related]
19. Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.
Mahaman YAR; Huang F; Wu M; Wang Y; Wei Z; Bao J; Salissou MTM; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Chen D; Wang X
J Alzheimers Dis; 2018; 63(3):1141-1159. PubMed ID: 29710724
[TBL] [Abstract][Full Text] [Related]
20. Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.
de Andrade Teles RB; Diniz TC; Costa Pinto TC; de Oliveira Júnior RG; Gama E Silva M; de Lavor ÉM; Fernandes AWC; de Oliveira AP; de Almeida Ribeiro FPR; da Silva AAM; Cavalcante TCF; Quintans Júnior LJ; da Silva Almeida JRG
Oxid Med Cell Longev; 2018; 2018():7043213. PubMed ID: 29861833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
